William G. Paxton

2.3k total citations · 1 hit paper
13 papers, 1.6k citations indexed

About

William G. Paxton is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, William G. Paxton has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in William G. Paxton's work include Renin-Angiotensin System Studies (11 papers), Receptor Mechanisms and Signaling (7 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). William G. Paxton is often cited by papers focused on Renin-Angiotensin System Studies (11 papers), Receptor Mechanisms and Signaling (7 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). William G. Paxton collaborates with scholars based in United States, Italy and Germany. William G. Paxton's co-authors include Kenneth E. Bernstein, Mario B. Marrero, Bradford C. Berk, Patrice Delafontaine, Bernhard Schieffer, Bernhard Schieffer, Jennifer L. Duff, Elisabeth Schieffer, Qing Chai and C. M. S. Cohen and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

William G. Paxton

13 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

1995 634 citations Mario B. Marrero, Bernhard Schieffer et al. Nature profile →

Peers

Countries citing papers authored by William G. Paxton

Since Specialization

Citations

This map shows the geographic impact of William G. Paxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William G. Paxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William G. Paxton more than expected).

Fields of papers citing papers by William G. Paxton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William G. Paxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William G. Paxton. The network helps show where William G. Paxton may publish in the future.

Co-authorship network of co-authors of William G. Paxton

This figure shows the co-authorship network connecting the top 25 collaborators of William G. Paxton. A scholar is included among the top collaborators of William G. Paxton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William G. Paxton. William G. Paxton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	KRYSTAL-12: A randomized phase 3 study of adagrasib (MRTX849) versus docetaxel in patients (pts) with previously treated non-small-cell lung cancer (NSCLC) with KRAS^G12C mutation. 2021 ·Journal of Clinical Oncology ·Tony Mok, William Lawler, (unknown), Shaker R. Dakhil, Alexander I. Spira, Fabrice Barlési, Martin Reck, Marina Chiara Garassino, David R. Spigel, Delia Alvarez, Thian Kheoh, William G. Paxton, Richard C. Chao, Enriqueta Felip	23
2	Validation of the Intrinsic Hepcidin IDxTM Test, an LDT for Clinical Hepcidin Assessment 2016 ·Blood ·(unknown), (unknown), Huiling Han, Vaughn Ostland, Gordana Olbina, William G. Paxton, Mark Westerman	2
3	Angiotensin II Controls p21 Activity via pp60 1996 ·Journal of Biological Chemistry ·Bernhard Schieffer, William G. Paxton, Qing Chai, Mario B. Marrero, Kenneth E. Bernstein	128
4	Angiotensin II signalling events mediated by tyrosine phosphorylation 1996 ·Cellular Signalling ·Mario B. Marrero, William G. Paxton, (unknown), Brian N. Ling, Kenneth E. Bernstein	42
5	Importance of Tyrosine Phosphorylation in Angiotensin II Type 1 Receptor Signaling 1996 ·Hypertension ·Bernhard Schieffer, William G. Paxton, Mario B. Marrero, Kenneth E. Bernstein	51
6	Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor breakdown → 1995 ·Nature ·Mario B. Marrero, Bernhard Schieffer, William G. Paxton, (unknown), Bradford C. Berk, Patrice Delafontaine, Kenneth E. Bernstein	634
7	Electroporation of pp60c− Antibodies Inhibits the Angiotensin II Activation of Phospholipase C-γ1 in Rat Aortic Smooth Muscle Cells 1995 ·Journal of Biological Chemistry ·Mario B. Marrero, Bernhard Schieffer, William G. Paxton, Elisabeth Schieffer, Kenneth E. Bernstein	152
8	The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling 1995 ·Cardiovascular Research ·Mario B. Marrero, Bernhard Schieffer, William G. Paxton, Jennifer L. Duff, Bradford C. Berk, Kenneth E. Bernstein	33
9	Angiotensin II signal transduction and the mitogen-activated protein kinase pathway 1995 ·Cardiovascular Research ·Jennifer L. Duff, Mario B. Marrero, William G. Paxton, Bernhard Schieffer, Kenneth E. Bernstein, Bradford C. Berk	84
10	The Angiotensin II AT1 Receptor Is Tyrosine and Serine Phosphorylated and can Serve as a Substrate for the SRC Family of Tyrosine Kinases 1994 ·Biochemical and Biophysical Research Communications ·William G. Paxton, Mario B. Marrero, Janet D. Klein, Patrice Delafontaine, Bradford C. Berk, Kenneth E. Bernstein	66
11	Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. 1994 ·Journal of Biological Chemistry ·Mario B. Marrero, William G. Paxton, Jennifer L. Duff, Bradford C. Berk, Kenneth E. Bernstein	185
12	Angiotensin II induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells. 1993 ·Journal of Biological Chemistry ·Jennifer L. Duff, Mario B. Marrero, William G. Paxton, (unknown), Lester F. Lau, Kenneth E. Bernstein, Bradford C. Berk	77
13	Immunohistochemical localization of rat angiotensin II AT1 receptor 1993 ·American Journal of Physiology-Renal Physiology ·William G. Paxton, Marschall S. Runge, Chris Horaist, C. M. S. Cohen, R. Wayne Alexander, Kenneth E. Bernstein	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact